|
SMARCD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.956750E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.299990E-02 |
| Normal-vs-Stage2 |
4.257800E-01 |
| Normal-vs-Stage3 |
4.387200E-04 |
| Normal-vs-Stage4 |
4.570100E-04 |
| Stage1-vs-Stage2 |
3.282600E-01 |
| Stage1-vs-Stage3 |
5.169500E-02 |
| Stage1-vs-Stage4 |
6.332400E-02 |
| Stage2-vs-Stage3 |
2.498400E-02 |
| Stage2-vs-Stage4 |
3.646000E-02 |
| Stage3-vs-Stage4 |
9.380600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.236700E-03 |
| Normal-vs-AfricanAmerican |
5.164600E-01 |
| Normal-vs-Asian |
1.094600E-01 |
| Caucasian-vs-AfricanAmerican |
3.015200E-01 |
| Caucasian-vs-Asian |
4.670000E-01 |
| AfricanAmerican-vs-Asian |
6.487800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.052200E-02 |
| Normal-vs-Female |
1.341360E-03 |
| Male-vs-Female |
4.036400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.275750E-02 |
| Normal-vs-Age(41-60Yrs) |
4.001100E-03 |
| Normal-vs-Age(61-80Yrs) |
4.597300E-03 |
| Normal-vs-Age(81-100Yrs) |
2.007800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.683200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.084200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.426600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.678400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.475000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.479600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.64809999997551E-06 |
| Classical-VS-Follicular |
6.572800E-01 |
| Classical-VS-Other |
7.977400E-01 |
| Classical-VS-Normal |
5.354200E-02 |
| Tall-VS-Follicular |
4.793700E-04 |
| Tall-VS-Other |
2.415000E-01 |
| Tall-VS-Normal |
1.18190000009122E-07 |
| Follicular-VS-Other |
9.436200E-01 |
| Follicular-VS-Normal |
4.511700E-02 |
| Other-VS-Normal |
4.688800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.531550E-02 |
| Normal-vs-N1 |
1.035750E-04 |
| N0-vs-N1 |
3.581600E-02 |
|
|
